ミルセラの世界市場レポート 2025年：疫学、パイプライン分析、市場インサイトと予測

ミルセラ市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）5%で35億630万米ドルに成長します。予測期間の成長は、特に市場を中心とした世界のがん罹患率の上昇、市場を中心とした継続的なヘルスケア支出の増加、貧血をより効果的に管理するための革新的な治療オプションに対する高い需要、貧血治療に対する需要の増加、病院と外来の両方におけるミルセラの採用などに起因すると考えられます。予測期間における主要動向としては、長時間作用型ESAの需要増加、技術の進歩、ヘルスケアインフラの開発、慢性腎臓病（CKD）管理における採用の増加、患者中心のドラッグデリバリーシステムへの注目の高まりなどが挙げられます。

慢性腎臓病（CKD）の有病率の上昇は、今後ミルセラ市場の成長を促進すると予想されます。CKDは、糖尿病や高血圧などの病態に伴う腎機能の漸減を特徴とする健康上の懸念です。CKDの発生率の増加は、人口の高齢化、ライフスタイルの変化、診断方法の改善などの要因によってもたらされています。貧血は、エリスロポエチン産生の減少によって引き起こされるCKDの一般的な合併症であり、ヘモグロビン値を管理し安定させるためにミルセラのような赤血球造血刺激剤を使用する必要があります。例えば、2023年6月、Kidney Research UKによると、英国では約720万人がCKDを患っており、2033年にその数は761万人に増加すると予想されています。したがって、CKDの有病率の上昇がミルセラ市場の成長を牽引しています。

ミルセラ市場の主要動向は、CKDに伴う貧血治療のために、特に小児患者向けに承認されたソリューションの開発に注力していることです。CKDによる貧血の小児患者には、赤血球産生を促進する長時間作用型の赤血球造血刺激因子製剤であるミルセラ（メトキシポリエチレングリコール-エポエチンベータ）が有効です。これにより、頻繁な注射の必要性を減らし、輸血のリスクを最小限に抑え、ヘモグロビン値を改善し、全体的な成長と生活の質を向上させています。例えば、2024年4月、Vifor Pharmaは、ミルセラのCKD関連貧血治療における使用について、3ヶ月から17歳の小児患者を含むFDAの承認を取得しました。この承認は、透析患者と非透析患者、特に他のESAからの移行患者に適用されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 バイオ医薬品市場における製品特性

• 分子タイプ
• 投与経路（ROA）
• 作用機序（MOA）
• 安全性と有効性

第4章 市場動向と戦略

第5章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第6章 世界の成長分析と戦略分析フレームワーク

• 世界のミルセラ：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のミルセラ市場：成長率分析
• 世界のミルセラ市場の実績：規模と成長、2019～2024年
• 世界のミルセラ市場の予測：規模と成長、2024～2029年、2034年
• 世界のミルセラ：総潜在市場規模（TAM）

第7章 世界市場の価格分析と予測

第8章 市場セグメンテーション

• 世界のミルセラ市場：配合別、実績と予測、2019～2024年、2024～2029年、2034年
• 注射液
• プレフィルドシリンジ
• 世界のミルセラ市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
• 慢性腎臓病による貧血
• がん患者の貧血
• 世界のミルセラ市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 透析センター
• 専門クリニック
• 小売薬局
• 世界のミルセラ市場：エンドユーザー患者別、実績と予測、2019～2024年、2024～2029年、2034年
• 成人患者
• 高齢患者

第9章 臨床適応症の世界市場疫学

• 薬剤の副作用
• 臨床適応症の発症率と有病率

第10章 地域別・国別分析

• 世界のミルセラ市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のミルセラ市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第11章 アジア太平洋市場

第12章 中国市場

第13章 インド市場

第14章 日本市場

第15章 オーストラリア市場

第16章 韓国市場

第17章 西欧市場

第18章 英国市場

第19章 ドイツ市場

第20章 フランス市場

第21章 東欧市場

第22章 北米市場

第23章 米国市場

第24章 カナダ市場

第25章 南米市場

第26章 中東市場

第27章 アフリカ市場

第28章 競合情勢と企業プロファイル

• ミルセラ市場：競合情勢
• ミルセラ市場：企業プロファイル
  • Roche

第29章 世界市場：パイプライン分析

第30章 世界の市場競合ベンチマーキングとダッシュボード

第31章 主要な合併と買収

第32章 最近の市場動向

第33章 市場の潜在力が高い国、戦略

• ミルセラ市場、2029年：新たな機会を提供する国
• ミルセラ市場、2029年：新たな機会を提供するセグメント
• ミルセラ市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第34章 付録

Mircera is a medication designed to treat anemia associated with chronic kidney disease (CKD) and anemia in cancer patients. As a long-acting erythropoiesis-stimulating agent (ESA), it works by stimulating red blood cell production to maintain healthy hemoglobin levels. Its extended dosing schedule, typically requiring injections once every two to four weeks, makes it convenient for patients.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main formulation types of mircera include injectable solutions and pre-filled syringes. These formulations are used to treat anemia resulting from chronic kidney disease and cancer-related anemia. Mircera is distributed through hospitals, dialysis centers, specialty clinics, and retail pharmacies. The medication serves various end-users, including adult and geriatric patients.

The mircera market research report is one of a series of new reports from The Business Research Company that provides mircera market statistics, including mircera industry global market size, regional shares, competitors with a mircera market share, detailed mircera market segments, market trends and opportunities, and any further data you may need to thrive in the mircera industry. This mircera market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mircera market size is expected to see strong growth in the next few years. It will grow to $3,506.3 million in 2029 at a compound annual growth rate (CAGR) of 5%. The growth in the forecast period can be attributed to the expected rise in the global cancer burden, particularly in developing regions, continued increase in healthcare expenditure, particularly in emerging markets, high demand for innovative treatment options to manage anemia more effectively, increasing demand for anemia treatments, adoption of Mircera in both hospital and outpatient settings. Major trends in the forecast period include rising demand for long-acting ESAs, technological advancements, healthcare infrastructure development, increasing adoption in chronic kidney disease (CKD) management, and increasing focus on patient-centric drug delivery systems.

The rising prevalence of chronic kidney disease (CKD) is expected to propel the growth of the mircera market going forward. CKD is a health concern characterized by the gradual loss of kidney function, often associated with conditions such as diabetes and hypertension. The increasing incidence of CKD is driven by factors such as aging populations, lifestyle changes, and improved diagnostic practices. Anemia, a common complication of CKD caused by reduced erythropoietin production, necessitates the use of erythropoiesis-stimulating agents like Mircera to manage and stabilize hemoglobin levels. For instance, in June 2023, according to Kidney Research UK, approximately 7.2 million people in the UK are living with CKD, and by 2033, the number is expected to rise to 7.61 million. Therefore, the rising prevalence of CKD drives the growth of the mircera market.

A key trend in the mircera market is focusing on developing approved solutions, particularly for pediatric patients, for the treatment of anemia associated with CKD. Pediatric patients with anemia due to CKD can benefit from Mircera (methoxy polyethylene glycol-epoetin beta), a long-acting erythropoiesis-stimulating agent that helps stimulate red blood cell production. This reduces the need for frequent injections, minimizes the risk of blood transfusions, and improves hemoglobin levels, enhancing overall growth and quality of life. For instance, in April 2024, Vifor Pharma received FDA approval to include pediatric patients aged 3 months to 17 years for Mircera's use in treating CKD-related anemia. This approval applies to both dialysis and non-dialysis patients, especially those transitioning from another ESA.

In August 2022, CSL Limited, an Australia-based biotechnology company, acquired Vifor Pharma, the developer of Mircera. This acquisition aims to expand CSL's presence in the nephrology space and enhance its portfolio of treatments for anemia in CKD patients.

The Key player operating in the mircera market is Roche

North America was the largest region in the mircera market in 2024. The regions covered in mircera report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mircera market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mircera market consists of sales of solutions and pre-filled syringes designed to treat anemia caused by chronic kidney disease (CKD). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mircera Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mircera market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mircera ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mircera market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Formulation: Injectable Solution; Pre-filled Syringes
• 2) By Indication: Anemia Due to Chronic Kidney Disease; Anemia in Cancer Patients
• 3) By Distribution Channel: Hospitals; Dialysis Centers; Specialty Clinics; Retail Pharmacies
• 4) By End User Patients: Adult Patients; Geriatric Patients
• Companies Mentioned: Roche
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mircera Market Characteristics

3. Mircera Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Mircera Market Trends And Strategies

5. Mircera Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Mircera Growth Analysis And Strategic Analysis Framework

• 6.1. Global Mircera PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Mircera Market Growth Rate Analysis
• 6.4. Global Mircera Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Mircera Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Mircera Total Addressable Market (TAM)

7. Global Mircera Market Pricing Analysis & Forecasts

8. Mircera Market Segmentation

• 8.1. Global Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Solution
• Pre-filled Syringes
• 8.2. Global Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anemia Due to Chronic Kidney Disease
• Anemia in Cancer Patients
• 8.3. Global Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Dialysis Centers
• Specialty Clinics
• Retail Pharmacies
• 8.4. Global Mircera Market, Segmentation By End User Patients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adult Patients
• Geriatric Patients

9. Global Mircera Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Mircera Market Regional And Country Analysis

• 10.1. Global Mircera Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Mircera Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Mircera Market

• 11.1. Asia-Pacific Mircera Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Mircera Market

• 12.1. China Mircera Market Overview
• 12.2. China Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Mircera Market

• 13.1. India Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Mircera Market

• 14.1. Japan Mircera Market Overview
• 14.2. Japan Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Mircera Market

• 15.1. Australia Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Mircera Market

• 16.1. South Korea Mircera Market Overview
• 16.2. South Korea Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Mircera Market

• 17.1. Western Europe Mircera Market Overview
• 17.2. Western Europe Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Mircera Market

• 18.1. UK Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Mircera Market

• 19.1. Germany Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Mircera Market

• 20.1. France Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mircera Market

• 21.1. Eastern Europe Mircera Market Overview
• 21.2. Eastern Europe Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Mircera Market

• 22.1. North America Mircera Market Overview
• 22.2. North America Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Mircera Market

• 23.1. USA Mircera Market Overview
• 23.2. USA Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Mircera Market

• 24.1. Canada Mircera Market Overview
• 24.2. Canada Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Mircera Market

• 25.1. South America Mircera Market Overview
• 25.2. South America Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Mircera Market

• 26.1. Middle East Mircera Market Overview
• 26.2. Middle East Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Mircera Market

• 27.1. Africa Mircera Market Overview
• 27.2. Africa Mircera Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Mircera Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Mircera Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Mircera Market Competitive Landscape And Company Profiles

• 28.1. Mircera Market Competitive Landscape
• 28.2. Mircera Market Company Profiles
  • 28.2.1. Roche Overview, Products and Services, Strategy and Financial Analysis

29. Global Mircera Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Mircera Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Mircera Market

32. Recent Developments In The Mircera Market

33. Mircera Market High Potential Countries, Segments and Strategies

• 33.1 Mircera Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Mircera Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Mircera Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer